[go: up one dir, main page]

MX2012001875A - Proceso para la preparación de inhibidores de la catepsina s. - Google Patents

Proceso para la preparación de inhibidores de la catepsina s.

Info

Publication number
MX2012001875A
MX2012001875A MX2012001875A MX2012001875A MX2012001875A MX 2012001875 A MX2012001875 A MX 2012001875A MX 2012001875 A MX2012001875 A MX 2012001875A MX 2012001875 A MX2012001875 A MX 2012001875A MX 2012001875 A MX2012001875 A MX 2012001875A
Authority
MX
Mexico
Prior art keywords
cathepsin
inhibitors
preparation
enzyme
synthetic processes
Prior art date
Application number
MX2012001875A
Other languages
English (en)
Inventor
Jimmy T Liang
Neelakandha S Mani
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of MX2012001875A publication Critical patent/MX2012001875A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Epoxy Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Inhibidores de la enzima de Catepsina S y sus procesos sintéticos.
MX2012001875A 2009-08-12 2010-08-11 Proceso para la preparación de inhibidores de la catepsina s. MX2012001875A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23323109P 2009-08-12 2009-08-12
PCT/US2010/045204 WO2011019842A1 (en) 2009-08-12 2010-08-11 Process for the preparation of cathepsin s inhibitors

Publications (1)

Publication Number Publication Date
MX2012001875A true MX2012001875A (es) 2012-07-20

Family

ID=42954808

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012001875A MX2012001875A (es) 2009-08-12 2010-08-11 Proceso para la preparación de inhibidores de la catepsina s.

Country Status (16)

Country Link
US (2) US20120142928A1 (es)
EP (1) EP2464646B1 (es)
JP (1) JP2013501804A (es)
KR (1) KR20120062752A (es)
CN (1) CN102574850A (es)
AU (1) AU2010282506A1 (es)
BR (1) BR112012003270A2 (es)
CA (1) CA2770904A1 (es)
CL (1) CL2012000353A1 (es)
IL (1) IL217997A0 (es)
MX (1) MX2012001875A (es)
NZ (1) NZ598129A (es)
RU (1) RU2012108619A (es)
SG (1) SG178319A1 (es)
WO (1) WO2011019842A1 (es)
ZA (1) ZA201201740B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016109684A2 (en) * 2014-12-30 2016-07-07 Novira Therapeutics, Inc. Derivatives and methods of treating hepatitis b infections
CN110128288B (zh) * 2018-02-02 2023-07-28 浙江九洲药业股份有限公司 一种氨基取代的环戊烷甲酸烷基酯衍生物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3989707A (en) * 1974-06-21 1976-11-02 Janssen Pharmaceutica N.V. Benzimidazolinone derivatives
WO2001034150A1 (en) * 1999-11-12 2001-05-17 Merck & Co., Inc. Aliphatic amine substituted piperidyl diaryl pyrrole derivatives as antiprotozoal agents
CN1294130C (zh) * 2000-08-10 2007-01-10 奥索-麦克尼尔药品公司 取代的吡唑
HU230538B1 (hu) * 2000-08-14 2016-11-28 Ortho Mcneil Pharmaceutical, Inc. Szubsztituált pirazolok és ezeket tartalmazó gyógyszerkészítmények

Also Published As

Publication number Publication date
SG178319A1 (en) 2012-03-29
US20140179924A1 (en) 2014-06-26
JP2013501804A (ja) 2013-01-17
CL2012000353A1 (es) 2013-01-25
ZA201201740B (en) 2013-10-28
BR112012003270A2 (pt) 2019-09-24
CA2770904A1 (en) 2011-02-17
CN102574850A (zh) 2012-07-11
IL217997A0 (en) 2012-03-29
RU2012108619A (ru) 2013-09-20
AU2010282506A1 (en) 2012-03-08
EP2464646B1 (en) 2014-05-07
US20120142928A1 (en) 2012-06-07
NZ598129A (en) 2013-05-31
KR20120062752A (ko) 2012-06-14
EP2464646A1 (en) 2012-06-20
WO2011019842A1 (en) 2011-02-17

Similar Documents

Publication Publication Date Title
WO2010114982A3 (en) Lyophilization cakes of proteasome inhibitors
SG176656A1 (en) Microorganisms for the production of 1,4-butanediol and related methods
TN2011000673A1 (en) Bace inhibitors
EP3611254C0 (en) MICROORGANISMS AND METHODS FOR HEXAMETHYLENEDIAMINE BIOSYNTHESIS
EP2558582A4 (en) MICROORGANISMS AND PROCESSES FOR THE PRODUCTION OF ETHYLENE GLYCOL
IL219094A (en) Process for making 2sglt and 2sglt inhibitors manufactured using them
MX2011007572A (es) Cubiertas externas reusables para articulos absorbentes para llevar puestos.
AU330642S (en) Holder
IN2012DN00939A (es)
MX2011007576A (es) Articulos absorbentes reusables para llevar puestos con sistema secundario de fijacion.
EP2652141A4 (en) MICROORGANISMS AND METHOD FOR PRODUCING 1,4-CYCLOHEXANDIMETHANOL
ZA201000482B (en) Process for the synthesis of e1 activating enzyme inhibitors
MY150292A (en) Process for the preparation of triamides from ammonia and amido-dichlorides
MY161868A (en) Anti-bv8 antibodies and uses thereof
MX2012007341A (es) Inhibidores de proteasoma y procesos para su preparacion, purificacion y uso.
MX2009004030A (es) Articulos antimicrobianos y metodos de fabricacion.
EP2387609A4 (en) Nonembryonic stem cells and their use
IN2013MN00733A (es)
UA112760C2 (uk) Теобромін у комбінації з гвайфенезином для лікування кашлю
WO2013072933A3 (en) Process for preparation of 2-acetamido-n-benzyl-3-methoxypropionamide
GB2452892B (en) Process for culturing bacteria of the piscirickettsia genus
SG143133A1 (en) Continuous processes for the production of ethoxylates
MX2012001875A (es) Proceso para la preparación de inhibidores de la catepsina s.
MX2011010046A (es) Derivados de diaminopteridina.
IN2012DN01846A (es)

Legal Events

Date Code Title Description
FG Grant or registration